Skip to content

Evaluation of a Combined Strategy Addressed to Practitioners and Chronic Obstructive Pulmonary Disease (COPD) Patients to Improve Clinical Control and Quality of Life

Evaluation of a Combined Strategy Addressed to Practitioners and COPD Patients: Information Feed-back and Health Education, to Improve Clinical Control and Quality of Life

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00922545
Enrollment
801
Registered
2009-06-17
Start date
2004-04-30
Completion date
2010-12-31
Last updated
2009-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Chronic obstructive pulmonary disease, Quality of life, Primary health care

Brief summary

Main objective: Evaluate the effectiveness of a combined strategy addressed to health care workers and patients, in relation to improving clinical control and patient's quality of life.It includes a feed-back about the health status of the patients, an education plan addressed to practitioners based in a CPG and in health education

Detailed description

Method/design: Design: Multicenter intervention study(before-after), quasi-experimental, prospective, with a control group and 12 month's follow-up Setting: 21 primary Health Care Centres in Barcelona (Spain) Sample: 801 patients (≥ 40 years old) with a register of COPD diagnostic,with one visit motivated by COPD during 2003 and that accept to participate at the study, after having read and signed the informed consent. Intervention: The program includes giving clinical results to the health care workers(doctor and nurse), from the medical records and interview. A training course (20h)that deals with aspects related to GPC, motivational interview and health education (tobacco, inhalers, alimentation, exercise and physiotherapy). Main variables: socio-demographic characteristics, quality of life, dyspnea, pharmacological treatment, exacerbations and hospital admissions, evaluation of inhalers technique, tobacco consumption, lifestyles and health resources used. Measures: quality of life was evaluated with the Saint george's Respiratory Questionnaire (SGRQ) and dyspnea with the modified scale of the Medical Research Council (MRC). The variables are obtained at the beginning of the intervention and at the end (12 months after). Information about possible changes in lifestyle is gathered during the follow-up visits.

Interventions

OTHERImplementation of Clinical Practice Guidelines (GPC) and Health Education Program

Intervention: The program includes giving clinical results to the health care workers(doctor and nurse), from the medical records and interview. A training course (20h)that deals with aspects related to GPC, motivational interview and health education (tobacco, inhalers, alimentation, exercise and physiotherapy).

Sponsors

Unitat de Suport a la Recerca de la Direcció d'Atenció Primària de Costa de Ponent
CollaboratorUNKNOWN
Societat Catalana de Medicina Familiar i Comunitària, Assoc. (CAMFiC)
CollaboratorOTHER
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients of both genders aged ≥40 years of age, recorded as having COPD, receiving attention in the PCC or at home, who have had at least one clinical visit for COPD management, and who provide written informed consent to participation in the study.

Exclusion criteria

* Patients who have any psychiatric disturbances, severe visual or auditory impairment that would impede compliance with the study protocol. * Patients with asthma, tuberculosis or other chronic respiratory pathologies, or any end-stage disease, or not having access to a telephone.

Design outcomes

Primary

MeasureTime frame
Quality of life (Saint George's Respiratory Questionnaire (SGRQ)Beginning of the intervention and at the end (12 months after)

Secondary

MeasureTime frame
Dyspnea, exacerbations and hospital admissionsBeginning of the intervention and at the end (12 months after)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026